Clark Capital Management Group, Inc.
Position in JNJ — Johnson & Johnson
CIK 1352187
PHILADELPHIA, PA
Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$249,008,696
+$20,374,431 QoQ
Shares Held
980,465
+4.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#180
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Capital Management Group, Inc. holds $673,709,624 across 9 Drug Manufacturers - General names. JNJ ranks #1 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
980,465 | $249,008,696 | |
| 2 | LLY |
ELI LILLY & Co
|
141,416 | $169,618,607 | |
| 3 | AZN |
Astrazeneca PLC
|
608,068 | $115,301,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
652,471 | $83,842,523 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
395,783 | $50,003,224 | |
| 6 | ABBV |
AbbVie Inc.
|
10,043 | $2,527,220 | |
| 7 | NVS |
Novartis AG
|
14,258 | $2,234,513 | |
| 8 | AMGN |
Amgen Inc
|
1,626 | $588,807 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,008,696 | 980,465 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $228,634,265 | 935,339 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $206,494,503 | 997,799 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $166,887,085 | 900,049 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $114,930,016 | 752,406 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $83,715,866 | 504,799 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $59,155,943 | 409,044 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $77,237,633 | 476,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $91,932,739 | 628,987 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $80,309,582 | 507,678 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $68,905,568 | 439,617 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $113,261,711 | 727,202 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $81,237,547 | 490,802 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,143,290 | 375,118 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $64,786,387 | 366,750 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $79,481,011 | 486,539 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $92,086,152 | 518,766 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $93,258,248 | 526,199 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $91,020,530 | 532,066 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $89,431,271 | 553,754 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $75,009,087 | 455,318 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $71,507,698 | 435,094 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $70,909,919 | 450,565 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $67,322,791 | 452,195 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $59,807,688 | 425,284 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $56,339,742 | 429,648 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||